Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc., commonly referred to as Cyrus Bio, is a pioneering company headquartered in the United States, with significant operations across various regions. Founded in 2014, Cyrus Bio operates at the intersection of biotechnology and computational science, specialising in protein design and engineering. The company is renowned for its innovative software solutions, particularly the Cyrus Bench platform, which streamlines the process of protein design, making it accessible and efficient for researchers and biopharmaceutical companies. With a strong focus on enhancing drug development and therapeutic applications, Cyrus Bio has established itself as a leader in the biotech industry, recognised for its unique approach to computational protein design. Through its commitment to advancing biotechnological research, Cyrus Bio continues to achieve notable milestones, solidifying its position as a key player in the evolving landscape of biotechnology.
DitchCarbon Score
How does Cyrus Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cyrus Biotechnology, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cyrus Biotechnology, Inc.'s reported carbon emissions
Cyrus Biotechnology, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cyrus Biotechnology may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As such, the company does not inherit any emissions data from a parent organisation, nor does it participate in recognised frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without specific emissions data or reduction initiatives, it remains unclear how Cyrus Biotechnology is addressing climate change within its operational framework.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cyrus Biotechnology, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
